In vivo performance of a drug-eluting contact lens to treat glaucoma for a month.

Autor: Ciolino JB; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA; David H. Koch Institute for Integrative Cancer Research, 77 Massachusetts Ave, Building 76-66, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA., Stefanescu CF, Ross AE, Salvador-Culla B, Cortez P, Ford EM, Wymbs KA, Sprague SL, Mascoop DR, Rudina SS, Trauger SA, Cade F, Kohane DS

Publikováno v: Biomaterials [Biomaterials] 2014 Jan; Vol. 35 (1), pp. 432-9. Date of Electronic Publication: 2013 Oct 04.

Sustained latanoprost release from PEGylated solid lipid nanoparticle-laden soft contact lens to treat glaucoma.

Autor: Dang, Hui¹ (AUTHOR), Dong, Chunyun² (AUTHOR), Zhang, Li³ (AUTHOR)

Publikováno v: Pharmaceutical Development & Technology. Feb2022, Vol. 27 Issue 2, p127-133. 7p.

A simple method for the subnanomolar quantitation of seven ophthalmic drugs in the rabbit eye.

Autor: Latreille, Pierre-Luc¹, Banquy, Xavier¹ xavier.banquy@umontreal.ca

Publikováno v: Analytical & Bioanalytical Chemistry. May2015, Vol. 407 Issue 13, p3567-3578. 12p.

Bimatoprost Imprinted Silicone Contact Lens to Treat Glaucoma.

Autor: Yan, Feng, Liu, Yanxia, Han, Shulan, Zhao, Qingsong, Liu, Nannan

Publikováno v: AAPS PharmSciTech; Feb2020, Vol. 21 Issue 2, p1-8, 8p

In Vivo Studies Evaluating the Use of Contact Lenses for Drug Delivery.

Autor: Hui, Alex, Willem, Mark, Willcox, Mark

Publikováno v: Optometry & Vision Science; Apr2016, Vol. 93 Issue 4, p367-376, 10p